Who has invested in HighlightLL Pharma?

Hankang Capital, Kaitai Capital, eFung Capital, Lakeside Capital are named among the investors backing HighlightLL Pharma.

HighlightLL Pharma Funding: $38M Raised, Series B (2021)

HighlightLL Pharma funding overview

HighlightLL Pharma is based in Hangzhou, China. HighlightLL Pharma has raised $38M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2021. The round record for HighlightLL Pharma runs through 2021; nothing later has been disclosed. Investors on record include Hankang Capital, Kaitai Capital, eFung Capital, Lakeside Capital. 4 distinct backers are named across the disclosed rounds.

HighlightLL Pharma at a glance

Total raised: $38M
Latest round: Series B
Latest round date: July 2021
Headquarters: Hangzhou, China
Notable investors: Hankang Capital, Kaitai Capital, eFung Capital, Lakeside Capital

Frequently asked about HighlightLL Pharma funding

How much has HighlightLL Pharma raised?: HighlightLL Pharma has raised $38M in total disclosed funding across the rounds on record.
Who has invested in HighlightLL Pharma?: Hankang Capital, Kaitai Capital, eFung Capital, Lakeside Capital are named among the investors backing HighlightLL Pharma.
What was the latest HighlightLL Pharma funding round?: The most recent disclosed round is a Series B, announced in July 2021.
Where is HighlightLL Pharma based?: HighlightLL Pharma is based in Hangzhou, China.
When did HighlightLL Pharma last raise?: The last disclosed HighlightLL Pharma round closed in July 2021 at Series B.

We update the HighlightLL Pharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Hangzhou and their backers are listed below.

HighlightLL Pharma Funding: $38M Raised, Series B (2021)

HighlightLL Pharma funding overview

HighlightLL Pharma at a glance

Frequently asked about HighlightLL Pharma funding

Companies related to HighlightLL Pharma (23)

Browse related funding lists (4)